• LAST PRICE
    4.4000
  • TODAY'S CHANGE (%)
    Trending Down-0.4100 (-8.5239%)
  • Bid / Lots
    4.2100/ 5
  • Ask / Lots
    4.4200/ 5
  • Open / Previous Close
    4.8000 / 4.8100
  • Day Range
    Low 4.3500
    High 4.8000
  • 52 Week Range
    Low 3.9300
    High 10.2812
  • Volume
    21,478
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 4.81
TimeVolumeCELZ
09:32 ET9754.8
09:38 ET1584.6
09:39 ET2104.7714
09:52 ET8424.6
10:24 ET5004.5
10:33 ET1004.53
11:04 ET5004.6926
11:22 ET1004.54
11:29 ET2554.54
11:40 ET3344.54
11:42 ET1004.5201
11:49 ET1004.52
12:03 ET2004.52
12:20 ET2504.5296
12:21 ET20494.52
12:23 ET1004.5111
12:45 ET40294.52
01:15 ET5004.5
01:17 ET1334.4
01:26 ET2524.485
01:57 ET10004.4622
02:13 ET1004.46
02:26 ET20374.4939
02:31 ET2504.4276
03:18 ET1004.35
03:32 ET9664.4
03:41 ET6814.45
03:45 ET3084.4465
03:50 ET1004.4
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCELZ
Creative Medical Technology Holdings Inc
6.5M
-1.2x
---
United StatesKZIA
Kazia Therapeutics Ltd
10.3M
-0.5x
---
United StatesPKTX
ProtoKinetix Inc
6.6M
-12.5x
---
United StatesTOVX
Theriva Biologics Inc
6.3M
-0.4x
---
United StatesENVB
Enveric Biosciences Inc
6.8M
-0.1x
---
United StatesEFTR
eFFECTOR Therapeutics Inc
6.8M
-0.1x
---
As of 2024-04-25

Company Information

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.

Contact Information

Headquarters
211 E. Osborn Rd.PHOENIX, AZ, United States 85012
Phone
480-399-2822
Fax
---

Executives

President, Chief Executive Officer, Director
Timothy Warbington
Chief Financial Officer, Senior Vice President, Director
Donald Dickerson
Independent Director
Michael Finger
Independent Director
Susan Snow
Independent Director
Bruce Urdang

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.5M
Revenue (TTM)
$9.0K
Shares Outstanding
1.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
5.04
EPS
$-3.76
Book Value
$7.53
P/E Ratio
-1.2x
Price/Sales (TTM)
725.0
Price/Cash Flow (TTM)
---
Operating Margin
-62,446.00%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.